Sievert, K., Chapple, C., Herschorn, S., Joshi, M., Zhou, J., Nardo, C., & Nitti, V. W. (2014). OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder. Int J Clin Pract.

Sievert, K-D, C. Chapple, S. Herschorn, M. Joshi, J. Zhou, C. Nardo, and V W. Nitti. "OnabotulinumtoxinA 100U Provides Significant Improvements in Overactive Bladder Symptoms in Patients With Urinary Incontinence Regardless of the Number of Anticholinergic Therapies Used or Reason for Inadequate Management of Overactive Bladder." Int J Clin Pract 2014.

Sievert, K-D, et al. "OnabotulinumtoxinA 100U Provides Significant Improvements in Overactive Bladder Symptoms in Patients With Urinary Incontinence Regardless of the Number of Anticholinergic Therapies Used or Reason for Inadequate Management of Overactive Bladder." Int J Clin Pract 2014.